-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Hold on Repligen, Lowers Price Target to $145

Benzinga·04/20/2026 16:15:25
Listen to the news
Canaccord Genuity analyst Kyle Mikson maintains Repligen (NASDAQ:RGEN) with a Hold and lowers the price target from $165 to $145.